Thomas Schinecker: A New Era for Health Innovation – Inside the Roche Genentech Innovation Center
Thomas Schinecker, CEO at Roche Group, shared a post on LinkedIn:
“When I arrived in Boston yesterday, I took a moment to look around.
Harvard Business School is right across the street. The i-lab and the Science and Engineering Complex are just minutes away.
Not long ago, this was an industrial rail yard. Today, it is a place for science, engineering and entrepreneurship.
That says a lot about why we opened the Roche Genentech Innovation Center here.
Our focus is on cardiovascular, renal and metabolic diseases.
These diseases do not exist in isolation.
So if we want to make a real difference, we cannot look at obesity, the heart or the kidney separately.
We have to understand how these diseases are connected. And to do that, we have to connect the science as well.
That is what the new center is meant to do: bring discovery, research, clinical development, AI and data science together, in one of the world’s strongest life sciences ecosystems.
Thank you to everyone at Harvard, across Boston and Massachusetts, and especially to our Roche and Genentech teams who bring this center to life.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026